Trial Profile

A Master Protocol for the Multi-cohort, Open-label, Phase 1/2 Study of DCC-3009 in Participants With Gastrointestinal Stromal Tumor (GIST)

Status: Recruiting

Phase of Trial: Phase I/II

Latest Information Update: 21 Nov 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs DCC 3009 (Primary) ; Antineoplastics
Indications Gastrointestinal stromal tumours
Focus Adverse reactions; Therapeutic Use
Sponsors Deciphera Pharmaceuticals

Most Recent Events

13 Nov 2025 According to Ono Pharmaceutical media release, data from this study will be presented during the CTOS Annual Meeting 2025, taking place November 12-15 in Boca Raton, Florida.
22 Oct 2024 Status changed from not yet recruiting to recruiting.
14 Oct 2024 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com